A carregar...
Eculizumab and drug-induced haemolytic–uraemic syndrome
The monoclonal anti-C5 antibody eculizumab has been successfully tested in atypical haemolytic-uraemic syndrome (aHUS), with or without mutations in the regulatory proteins of the alternative pathway of the complement, and less convincingly in enterohaemorrhagic Escherichia coli-associated HUS. Here...
Na minha lista:
| Publicado no: | Clin Kidney J |
|---|---|
| Main Authors: | , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Oxford University Press
2013
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4438394/ https://ncbi.nlm.nih.gov/pubmed/26120441 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/ckj/sft078 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|